Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia

doi:10.4254/wjh.v8.i6.331

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9269)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

399

WORD

333

HTML

3078

Figures (1-3)

271

Tables (1-5)

279

Sum=4360

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

484

Download

1055

Sum=1539

Publishing Process of This Article

Item

Count

Browse

1137

Download

2233

Sum=3370

Feb 28, 2016 (publication date) through Feb 11, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Hepatol. Feb 28, 2016; 8(6): 331-339
Published online Feb 28, 2016. doi: 10.4254/wjh.v8.i6.331

Table 3 Sustained virologic response at follow-up week 24 in the crossover group n (%)

	SVR
Total	19/27 (70.4)
TN TW12 failure (< 2 log decline HCV RNA)	8/11 (72.7)
TE TW12 failure (detectable HCV RNA)	11/16 (68.8)
TN TW24 failure (detectable HCV RNA)	0/0

HCV: Hepatitis C virus; SVR: Sustained virologic response; TE: Treatment-experienced; TN: Treatment-naive; TW: Treatment week.

Citation: Isakov V, Nikitin I, Chulanov V, Ogurtsov P, Lukyanova E, Long J, Wahl J, Helmond FA, The P08160 Trial Investigators. Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia. World J Hepatol 2016; 8(6): 331-339
URL: https://www.wjgnet.com/1948-5182/full/v8/i6/331.htm
DOI: https://dx.doi.org/10.4254/wjh.v8.i6.331